1. Adam HJ, Karlowsky JA, Nichol K, Gilmour MW, Hoban DJ, Embree J and Zhanel GG.  Baseline epidemiology ofStreptococcus pneumoniae serotypes in Canada prior to the introduction of the 13-valent pneumococcal vaccine. Microbial Drug Resistance 2012;18(2):176-182.
2. Zhanel GG, Lawson CD, Zelenitsky S, Findlay B, Schweizer F, Adam H, Walkty A, Rubinstein E, Gin AS, Hoban DJ, Lynch JP and Karlowsky JA. Comparison of the next generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. Expert Reviews in Antiinfective Therapy 2012;10(4):459-473.
3. Zhanel GG, Rossnagel E, Nichol K, Cox, L, Karlowsky JA, Zelenitsky S, Noreddin AM and Hoban DJ. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA), heteroresistant (h) vancomycin-intermediate Staphylococcus aureus (hVISA), VISA and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model. Journal of Antimicrobial Chemotherapy 2011;66(6):1301-1305. 
4. Bera S, Zhanel GG and Schweizer F. Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles: Polyol-modified neomycin B, kanamycin A, amikacin and neamine based amphiphiles with potent broad spectrum antibacterial activity. Journal of Medicinal Chemistry 2010;53(9):3626-3631. 
5. Zhanel GG, DeCorby M, Adam H, Lagace-Wiens P, Nichol KA, Wierzbowski A, Baudry PJ, Tailor F,  Karlowsky JA, Walkty A, Schweizer F, McCracken M, Mulvey MR, Johnson J, The Canadian Antimicrobial Resistance Alliance (CARA) and Hoban DJ. Prevalence of antimicrobial resistant pathogens in Canadian hospitals: Results of the Canadian ward surveillance study (CANWARD 2008). Antimicrobial Agents and Chemotherapy 2010;54(11):4684-4693.

Recent Patents:
Six patents on novel agents with antimicrobial activity.

Teaching Interests:

Prevention and treatment of infectious diseases. 25 years teaching experience to specialists, general practitioners and students in medicine, nursing, pharmacy, biomedical sciences and lab technology. Over 40 teaching awards/nominations and a member of the Who’s Who in Medical Sciences Education (WWMSE).

Presentations:
Presented over 800 lectures as an invited speaker at international, national, and local meetings speaking on the topics of prevention and treatment of infectious diseases in Canada, United States, Central America, Western and Eastern Europe including Russia, Australia, Southern and Northern Africa, the Middle East and Asia.

Consulting Interests:
Discovery and development of agents used to prevent and/or treat infectious diseases including antibiotics, antifungals, antivirals, antiparasitics, antituberculers, antiseptics, preservatives, disinfectants, sterilizers, agents with antimicrobial activity and vaccines.

Research Colleagues:

LOOKING FOR GRADUATE STUDENTS (MASTERS, PhD, POST-DOCS) WITHIN THE NEXT YEAR
1 masters student